CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host three free live continuing education (CE)-accredited webinars focused on rapidly evolving oncology therapies in May, announced Jim Palatine, R.Ph., MBA, president of PTCE.
“With the fast-paced changes to health care today, it is critical for pharmacists to have the most current and accurate information on the changing landscape of oncology care towards the use of more targeted therapies and immunotherapies,” Palatine said. “Live education offers pharmacists the opportunity to interact with the faculty and ask questions about strategies to improve patient outcomes. We look forward to presenting each of these live CE webinars.”
The PTCE webinars are:
- Considerations for Novel, Targeted Therapies in the Treatment of Patients with B-Cell Malignancies and Plasma Cell Disorders, available Wednesday, May 15, at 6 and 8 P.M. ET. The faculty presenter for this webinar will be Eric Chow, Pharm.D., BCOP, system pharmacy oncology manager at Novant Health. Chow will provide pharmacists with education on the changing landscape, including use of prognostic indicators and new molecular analyses and biomarkers that may help guide therapy decisions for chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma and Waldenstrom’s macroglobulinemia. Efficacy and safety of these agents and their specific role within this disease treatment paradigm will also be presented, along with the pharmacist’s role in helping to manage patients receiving these agents in a variety of practice settings. This activity is supported by educational grants from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech Inc., administered by Janssen Scientific Affairs LLC; and BeiGene Ltd. To register, click here.
- Safe and Efficacious Use of Immunotherapy Agents: Pharmacist-Driven Strategies to Improve Patient Outcomes, available Thursday, May 23, at 6 and 8 P.M. ET. The faculty presenter for this webinar will be Christopher J. Campen, Pharm.D., BCPS, BCOP, clinical oncology pharmacist at Greenville Health System Cancer Institute and a clinical assistant professor at the University of South Carolina School of Medicine Greenville. Campen will educate pharmacists about the changing landscape of these agents, including the use of biomarkers to help identify patients most likely to benefit from therapy with immune checkpoint inhibitors. This program will also review common adverse events associated with immunotherapy and evidence-based management strategies. This activity is supported by an educational grant from Bristol-Myers Squibb. To register, click here.
- Therapy Options for the Optimal Care of Patients with Multiple Myeloma, available Tuesday, May 28, at 6 and 8 P.M. ET. The faculty presenter for this webinar will be LeAnne Kennedy, Pharm.D., BCOP, CPP, FHOPA, clinical pharmacy specialist at Wake Forest Baptist Health. Kennedy will explore current and emerging treatments of multiple myeloma, including preferred combination regimens and management of therapy-induced adverse effects. This program will also address specific practices to optimize patient education and adherence for individuals receiving treatment for multiple myeloma. This activity is supported by an educational grant from Celgene Corporation. To register, click here.
Each webinar is accredited by the Accreditation Council for Pharmacy Education and approved for 1.0 contact hours.
About Pharmacy Times Continuing Education™
Pharmacy Times Continuing Education™ (PTCE) is a leader in continuing education for retail, health-system, managed care and specialty pharmacists. PTCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). PTCE’s print, online and live CPE activities are designed to help improve the knowledge, competence and skills of pharmacists so they are better prepared to provide the highest quality of pharmacy care to the patients they serve and to the physicians they assist as part of a multidisciplinary treatment/management team. To learn more about the educational activities sponsored by PTCE, visit our website at https://www.pharmacytimes.org/.